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Arising from progenitor cells in the bone marrow, B cells undergo differentiation
through a series of stages characterized by the orderly rearrangement and expres-
sion of Ig genes (1, 2). However, the very earliest stages of commitment to the B
lineage are poorly understood. Before the appearance ofcytoplasmic IgM, committed
pre-B lymphocytes can be distinguished by the appearance of class II MHC an-
tigens, followed by the B cell-specific 95-kD surface glycoprotein CD19 (3). All resting
B cells display CD19 antigens, and CD19 expression persists upon activation (4),
but is lost upon further differentiation to Ig-secreting plasma cells (4). Almost all
early B cell malignancies show CD19 expression (3). The observation that CD19 un-
dergoes antibody-induced internalization suggests that it may provide a suitable target
for immunotoxin-mediated treatment of aggressive forms of B cell lymphomas and
leukemias that respond poorly to conventional chemotherapy (5).
Although the physiological role of CD19 is not at present known, anti-CD19 mAbs
block the activation ofmature B cellselicited by anti-Ig antibodies (6), and one anti-
CD19 mAb, B43, induces pre-B cells to proliferate directly (5). This report describes
the isolation and expression ofa cDNA clone encoding CD19 . The extracellular por-
tion of CD19 is organized in Ig-like domains, and the intracellular portion bears
significant relatedness to an Epstein-Barr virus protein ofunknown function. Lesser,
but apparently significant homology was found with a segment of the EBV envelope
protein and the int-1 oncogene.
Materials and Methods
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Monoclonal Antibodies.
￿
The B cell panel of mAb was obtained from the Third Interna-
tional Leukocyte Typing Workshop. Anti-CD19 mAb included HD37, B4, BU12, SJ25-Cl,
and HD2/37. mAb B43 was a kind gift from Dr. Fatih Uckun (University of Minnesota,
Minneapolis, MN).
cDNA Library Construction and Cloning.
￿
A cDNA library was constructed from the Burkitt
lymphoma cell line Daudi as described (7, 8), was introduced into COS cells by the DEAE-
Dextran method (7, 8), and was enriched for CD19-encoding cDNAs by panning (7, 8). After
three rounds of introduction into COS cells and panning, plasmid DNA was prepared from
single colony isolates, transfected into COS cells, and scored for CD19 expression.
RNA Blots, DNA Blots, andSequencing.
￿
RNA and DNA blot hybridizations and sequencing
were performed as described (7, 8).
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Results and Discussion
To isolate acDNA clone encoding CD19, an expression library was constructed
from the Burkitt lymphoma line Daudi, introduced into COS cells by the DEAE-
Dextran method, and subjected to three rounds ofpanning and reintroduction into
Escherichia coli as described (7, 8) . After the third round of panning, one of eight
randomly picked colonies yielded DNA that when transfected into COS cells gave
a positive indirect immunofluorescence reaction with anti-CD19 mAbs . COS cells
transfected with the cDNA clone reacted with all anti-CD19 mAbs tested but with
no other mAbs from a large B cell panel (data not shown) . The positive plasmid
contained an insert of -1 .9 kb .
RNA blot hybridization analysis revealed a single RNA species of 2 kb whose
expression was restricted to B cell lines (Fig . 1) . The highest abundance of the mes-
sage was observed in the pre-B cell line Nalm-6, followed by the Burkitt lymphoma
line Raji . Weaker expression wasfound in the B-lymphoblastoid lines IM-9andLESS,
while no expression was observed in the plasmacytoma line RPMI 8226, consistent
with the observation that CD19 expression is lost upon terminal differentiation to
plasma cells (3, 4) . PeripheralT cells, theT cell leukemia lineJurkat, the promyelo-
cytic leukemia line HL60, the promonocytic leukemia line U937, and the hepatoma
line HepG2 were all negative for CD19 expression .
DNA blot hybridization analysis showed a simple pattern consistent with a single
copy gene (data not shown) .
The nucleotide sequence ofthecDNA insert consists of 1,920 nucleotides terminating
in a poly(A) tail 16 nucleotides downstream ofthe consensus polyadenylation signal
(AATAAA) (Fig . 2 a) . An open reading frame, starting at an ATG embedded in
an initiation consensus sequence (9), encodes a protein of 467 amino acids with a
predicted molecular weight (Mr) of 51,799 . The first methionine is followed by 19
predominantly hydrophobic amino acids . Excision of these residues, at a site corre-
sponding to the signal peptide cleavage rules predicted by von Heijne (10), yields
a mature protein ofM r 49,300 . The resulting extracellular domain would consist
of271 residues containing 5 potential N-linked glycosylation sites (Asn-XaaSer/Thr) .
The predicted extracellular domain is followed by 28 predominantly hydrophobic
amino acids, with the exception of one arginine residue, consistent with a trans-
FIGURE 1.
￿
RNAblot hybridization analysis . 20
kg of each RNA sample was electrophoresed
througha 1% agarose gel, denatured, transferred
to a nylon filter, and hybridized to a s2P-labeled
CD19 cDNA probe . Sources of RNA are indi-
cated. NALM-6 is a pre-B leukemia, IM-9 a B
lymphoblastoid line,JY and LESS EBVtrans-
formed B lymphoblastoid lines, Raji a Burkitt
lymphoma, RPMI 8226 a plasmcytoma, Jurkat
a T cell leukemia; T represents lymphokine-
activated peripheralT cells, HL60 and U937 are
myeloid leukemiacell lines and HepG2 a hepatob-
lastoma .A
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1 CAGAGTCTCACCACCATCCCACCICCTCOCCTCCTCTTCTTCCICCTCTTCCTCACCCCCATGCAACTCACOCCCOAGOAACCTCTAGTCOTGAAOGTGGAACAGGGAGATAACGCTGTG
1
￿
M P P P R L L F F L L F L T P M E V R P E E P L V V K V E E C D N A V
121 CTGCAGTGCCTCAAGQGOACCTCACATOCCCCCACTCAOCAOCTGACCTOGTCTCGOOAGTCCCCGCTTAAACCCTTCTTAAAACTCAGCCTGGCGCTGCCACGCCTCCGAATCCACAIG
36L Q C L K C T S 0 G P T Q Q L 7 W S R E S P L K P F L K L 5 L 0 L P G L 0 I N M
241 ACCCCCCTCC ,CATCTCCCTTTTCATCTTCAACGTCTCTCAACAOATOCGGOOCTTCTACCTOTGCCAOCCCOCGCCCCCCTCTGAGAACGCCTGCCACCCTGGCTGCACAGTCAATGTG
70 R P L A 1 W L F I F N V S Q Q M 0 0 F Y L C Q P 0 F P S E K A W Q P G W T V N V
361 CAOOOCAGCGGCCACCTOTTCCCGTGGAATGTTICCOACCTACOTGGCCTOGOCTOTOOCCTOAAGAACAOOTCCTCACAGCCCCCCAGCTCCCCTTCCGGGAACCTCATGAGCCCCAAG
110E 0 S G E L F R W N V S D L C C L 0 C 0 L K N R S 5 E 0 P 5 S P S C K L M 5 P K
401 CTOTATOTOTOOCCCAAACACCOCCCTGACATCTWOAGOOAOAOCCTCCOTOTOTCCCACCOAOCOACAGCCTWACCAOACCCTCAGCCAOGACCTCACCATCGCCCCTGGCTCCACA
166 L Y V W A K 0 R F E I W E 0 E P P C V P P R D 5 L N Q 5 L 5 Q D L T M A P G S T
601 CTCTGCCTOTCCTGTGGOGTACCCCCTGACTCTOTGTCCAOOCOCCCCCTCTCCTGGACCCATOTCCACCCCAAGGGCCCTAACTCATTGCTOAGCCTAGAGCTGAGGACCATCCCCCG
796 L W L S C 0 V P P D S V S R 0 P L S W T N V H P K 0 P K 5 L L S L E L K D D R P
721 OCCACACATATCTGGGTAATCOAGACOOOTCTOTTOTTOCCCCG06CCACAOCTCAAOACCCTGOAAACTATTATTOTCACCGTOOCAACCTGACCATCTCATTCCACCTCGAGATCACT
236 A R D M W V M E T G L L L P R A T A Q 0 A 0 K Y Y C H R 0 N L T M S F H L E I T
041 GCTCGCCCAGTACTATGGCACTCOCTOCTGAOOACTCOTOOCTCGAAOOTCTCAGCTGTGACTTTGCCTTATCTGATCTTCTGCCTGTOTTCCCTTGTGGGCATTCTTCATCTTCAAAGA
276 A R P V L W H W L L R T 0 0 W K != .! . .! ..!..T L A Y L I F C L C S _ L V C I L N L Q R
961 GCCCTGGTCCTCACGAGGAAAAGAAAGCCAATQACTOACCCCACCACCAGATTCTTCAAACTOACOCCTCCCCCAGCAAGCCCCCCCCAGMCCAGTACCGCAACGTCCTGTCTCTCCCC
316 A L V L R R K R K R M 7 0 P T R R F F K V T P P P 0 5 C P Q N Q T C N V L S L P
1001 ACACCCACCTCAGCCCTCCCACGCGCCCACCOTTCGGCCGCACCCCTGOGOOGCACTOCCCCCTCTTATGGAAACCCGAOCAOCOACOTCCACCCGGATO AGCCTTGGGGTCCCGGAGC
360 7 P T 5 0 L 0 R A Q R W A A C L 0 C T A P S Y 0 N P S 5 0 V Q A 0 G A L G S R 5
1201 CCCCGGGAGTCOCCCCACAAGAAGAGGMOGOMBGOCTATGAGBAACCTOACAOTGAOCACCACTCCGAGTTCTATCAGAACWCTCCAACCTTGGGCAGGACCAGCTCTCCCACCATG
39O R R E W A Q N K R K 0 R A M R N L T V R R T P 5 S M R T T P T L C R T 5 S P R M
1321 CCAGCGOCTACOAGAACCCTOACGATWOCCCCTGOOTCCTOAOWTOAAOACTCCTTCTCCAACGCTCAOTCTTATOAOAACOAGWTOAAGACCTQACCCAGCCGCTCGCCACGACAA
436 A A A T R T L R M S P W V L R M K T P S P T L S L M R T R M K S
1441 TGCACTTCCTGACCCCTCATGOOTCAOCCTOCOACCCCAOCC000AACCAACCTCCCTG00CTCCCAOTCCTATOAGGATATOAOAOCAATCCTOTATGCAGCCCCCCAGCTCCGCTCCA
1663 7T000GGCCACCCTGQACCCAATCATGAODAAOATGCAGACTCTTATOAOAACATGOATAATCCCQATGGOCCAGACCCAQCCTGCOGAGaAG=GCCOCATGCGCACCTGGACCACCA
1061 OCTGATCCTCAOOTOOCCACCCTGCATCTCCTCAAOTCCCCAAGATTCACACCTGACTCTOAAATCTOAAWCCTCGAOCAOATOATGCCAACCTCTGQAGCAATGTTGCTTAOGATGTG
1901 TOCATCTGTCTAACTOTGTCTCICICTOIGTOTGTOTCTCTCTQTOTAYACAT000ACTOACACTTCCAOTCCCCITTOTATTCCTTAAATAAACTCAATGACCTCTTCCAAAAAAAAAA
FIGURE 2 .
￿
(A) Sequence of the CD19 cDNA. The sitesof potential N-linked glycosylation are
denoted by the symbol-CHO-; the predicted transmembrane region is underscored. (B)
Hydropathicity profile of the amino acid sequence in A.
membrane region. Although uncommon, charged residues have been observed in
the transmembrane domainsofafew surface proteins, including the a and achains
ofthe T cell antigen receptor complex (11) and IgE Fc receptors (12). The predicted
cytoplasmic domain is composed of 148 residues and contains a large number of
serine and threonine residues (16 and 17, respectively) providing potential phosphory-
lation sites. The cytoplasmic domain is also arginine and proline rich (24 and 15
residues, respectively).
The predicted amino acid sequence was compared with the National Biomedical
Research Foundation(NBRF)databaseusingthe FASTP algorithm. Significant relat-
edness was found with members ofthe Ig family, two proteins encoded by Epstein-
Barr virus, and the transforming protein int-1. The Ig homology arises from the
extracellulardomain which is organized into three contiguous Ig-like domains (13).
Domains 1 and 3 have intercysteine distances of 59 and 61 residues, respectively,
only slightly shorter thanthe62-67 residue intercysteine spacing typical ofVregion
domains. The sequence surroundingthe second cysteinein domains 1 and 3 matches
the V region consensus D-X-G/A-XYC. Domain 2 has an intercysteine distance
ofonly39 residues, andthesequence around the second cysteine moreclosely resembles
that from C region domains (13).
Quantitative sequence comparisons were performed with the ALIGN program
of the NBRF Protein Identification Resource (14). A score for the test sequences
>3 SD above the mean for an ensemble ofrandomly permuted sequences is consid-
ered significant (13). Optimal alignmentofCD19 domains 1 and 3 gave a score 4.611208
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SD above the mean. When the two domains were compared with V regions in the
NBRF database, domain 3 showed greater homology to various V regions than did
domain 1 (Fig. 3). The greatest similarity was found with a rabbit V/K region, for
which a score 9.99 SD above the mean was found, corresponding to a probability
of 8 x 10-
z4 for an equally good or better match occurring between two proteins
of identical composition.
Surprisingly, significant homology was found between the cytoplasmic domain
of CD19 and the EBV proteins BSLF1 (15) and gp 220/350 (16), and the transforming
protein int-1 (17). BSLF-1 is a protein of unknown function, while gp 220/350 plays
a role in the attachment of EBV to cell membrane (16). int-1 is implicated in viral
mammary tumorigenesis and is expressed in the developing murine nervous system
(17). The ALIGN score for optimal alignment of CD19 and BSLF1, gp 220/350
and int-1 was 8 .42, 4.91, and 7.60 SD above the mean, respectively (Fig. 4).
The functional significance of the similarities between CD19 and EBV proteins
and int-1 is at present unclear. However, the degree ofrelatedness to BSLF1 appears
to eliminate coincidence as a plausible explanation. The CD19-related sequences
in BSLF1 may have arisen adventitiously, for example as a result of viral capture
a
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FIGURE 3.
￿
OptimalalignmentofthethirdIg-like domain ofCD19 (residues 191-265) with human
Ig heavychain VIII region, (NBRFcode H3HUTL) human Ig XchainV I region (LIHUNW),
and rabbit K chain V region (KVRB16) by the ALIGN program of the Protein Identification
Resource (NBRF) (28). Asterisks denote conserved residues between CD19 and at least one V
region. Residues conserved among all five proteins are denoted by the corresponding letter.
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FIGURE 4.
￿
Optimal alignment between segments of the cytoplasmic domain of CD19 and the
EBVproteinBSLFI (NBRFcode QQBE15)(a), theEBVprotein gp350/220(NBRFcode QQBE21)
(b), andthe int-1 oncogene (NBRF code TVHUTI). Conserved residues are displayed beneath
the aligned sequences; asterisks denote closely related residues.
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of cellular sequences, or they may serve some viral role. In the latter case, either
capture of cellular sequences or convergent evolution might account for the observed
homology. It will be interesting to see if the limits of homology correspond to exon
boundaries in the genomic DNA.
Summary
The isolation and expression ofa full-length cDNA clone encoding the B cell-specific
glycoprotein CD19 is reported. The sequence of the cDNA predicts a glycosylated
integral membrane protein with a precursor molecular weight of 51.8 x 103 and
an extracellular domain organized into three contiguous Ig-like sub-domains. The
cytoplasmic domain bears significant relatedness to two proteins encoded by the
Epstein-Barr virusand the int-1oncogene. CD19 transcripts are restricted to members
of the B cell lineage, being most abundant in pre-B cell lines and least abundant
in plasmacytomas.
Receivedforpublication 16 May 1988 and in revisedform 6July 1988.
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